AUTO-Treg
Regulatory T cells (Tregs) are key immune cells that help maintain immune balance by preserving necessary immune functions
while regulating unnecessary or excessive immune responses.
Tregs suppress excessive immune responses and help maintain immune tolerance. Their dysfunction or imbalance is a major pathophysiological driver of autoimmune and chronic inflammatory diseases.
AUTO-Treg isolates, expands, and reinfuses a patient’s own Tregs
to restore impaired immune regulatory function at its source.
Conventional autoimmune therapies largely rely on broad immunosuppression to control inflammation and symptoms,
but infection risk, recurrence, and long-term immune
imbalance remain unresolved challenges.
AUTO-Treg is an autologous Treg cell therapy platform that uses patient-derived Tregs to selectively modulate overactive immune responses and restore impaired immune tolerance and
homeostasis.
AUTO-Treg is an autologous Treg cell therapy platform that harnesses the immunoregulatory function of patient-derived Tregs
to restore disrupted immune homeostasis and immune tolerance.
AUTO-Treg combines the immune-regulatory function of autologous Treg cells with manufacturing and quality-system capabilities
to support scalable development for autoimmune and inflammatory diseases.
Key Features
Personalized immune modulation using patient-derived Tregs
Re-establishing physiological immune tolerance without broad immunosuppression
Selective control of pathological immune responses while preserving protective immunity
Expandable across multiple autoimmune and chronic inflammatory diseases
Building clinical, manufacturing, and CMC capabilities through regenerative medicine
The Future Envisioned by AUTO-Treg :
Autoimmune disease treatment is evolving beyond conventional immunosuppression toward restoring immune tolerance
and re-establishing immune homeostasis.
AUTO-Treg is building a next-generation autologous Treg cell therapy platformthat combines enhanced
Treg function with robust and reproducible manufacturing to deliver precise and durable immune regulation.
Starting with proof-of-concept(PoC)in selected autoimmune diseases, IMMUNIQUE is expanding this platform
to address a broad spectrum of immune-mediated disorders and unlock the potential of long-term, disease-modifying therapies.
